SYSTEMIC SCLERODERMA - PROGNOSIS DETERMINED BY INTERNAL MANIFESTATIONS

Citation
M. Mittag et Uf. Haustein, SYSTEMIC SCLERODERMA - PROGNOSIS DETERMINED BY INTERNAL MANIFESTATIONS, Hautarzt, 49(7), 1998, pp. 545-551
Citations number
40
Categorie Soggetti
Dermatology & Venereal Diseases
Journal title
ISSN journal
00178470
Volume
49
Issue
7
Year of publication
1998
Pages
545 - 551
Database
ISI
SICI code
0017-8470(1998)49:7<545:SS-PDB>2.0.ZU;2-L
Abstract
Prognosis of systemic sclerosis (scleroderma, Ssc) is largely dependin g on involvement of internal organs. Abnormalities of the gastrointest inal tract are found most frequently (85%), especially decreased motil ity of the oesophagus,which has little impact on the longterm clinical course of Ssc. Pulmonary manifestations can be demonstrated in 40-90% of patients; one must distinguish between pulmonary hypertension or f ibrotic lung disease. The heart is affected in 50% of cases. Patchy or diffuse myocardial fibrosis, as well as pericarditis and pericardial effusions can induce symptoms of arrhythmia or congestive heart failur e. Renal involvement is associated with increased mortality and occurs in 45% of Ssc, producing proteinuria, hypertension, scleroderma renal crisis and renal failure. In conclusion, involvement of the lungs, he art and kidneys are determining factors for the longterm course of sys temic sclerosis.